AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06193083 — intervention group
Intervention type: OTHER
Intervention: The self-administered questionnaires, rPATD and BMQ
Description: rPATD: The rPATD is a questionnaire validated and adapted in French to assess patients' perceptions of their treatments and deprescribing.~This self-administered questionnaire consists of 22 questions rated on a 5-point Likert scale (scale from 1 to 5, at 1 the patient completely agrees with the questionnaire's proposal, at 5 the patient strongly disagrees with the questionnaire's proposal)~BMQ French version of the BMQ self-questionnaire, which studies patients' perceptions of medication .~The Beliefs about Medicine Questionnaire (BMQ) is an 18-item self-administered questionnaire designed to explore patient perceptions of medicine. It has been validated in French and is free to use.~It comprises 10 items relating to specific beliefs about prescribed treatments:~A 5-point Likert-type scale was used for each item. The higher the sum of the scores obtained, the stronger the subject's belief.
Study NCT06193083 — intervention group
Intervention type: OTHER
Intervention: The self-administered FCCHL (Functional, Communicative and Critical Health Literacy) / HLS14 (14-item health literacy scale)
Description: FCCHL (Functional, Communicative and Critical Health Literacy)/HLS14 (14-item health literacy scale) (https://reflis.fr/wp-content/uploads/2020/07/FCCHL-HLS14-Questionnaire-Litteratie-sante.pdf )~Validated French-language self-administered questionnaire and consisting of14 items with a 5-point Likert scale for assessing health literacy :~Functional literacy: basic reading and writing skills sufficient to function effectively in everyday situations Communicative or interactive literacy: more advanced cognitive and literacy skills that, combined with social skills, can be used to actively participate in everyday activities, extract information and meanings from different forms of communication, and apply new information to changing circumstances Critical literacy: more advanced cognitive skills which, combined with social skills, can be applied to the critical analysis of information and the use of that information to exercise greater control over life events and situations
Study NCT05295329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound Danshen Dropping Pills
Description: use Compound Danshen Dropping Pills
Study NCT05295329 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: use placebo
Study NCT04883073 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of Endo App
Description: Use of Endo App
Study NCT04685330 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound guided procedure
Description: Single-arm, open-label device efficacy study to enroll 200 patients who have been ordered to have an ultrasound-guided procedure by the MGH Interventional Radiology department, including paracentesis, thoracentesis, biopsy, or ultrasound-guided drain placement. Patients will be restricted to adults who can consent.
Study NCT04685330 — intervention group
Intervention type: DEVICE
Intervention: Portable ultrasound
Description: The FDA approved Healcerion SONON portable ultrasound (linear and curved) will be used during clinically indicated standard ultrasound-guided procedures following clinical standard of care. A standard clinical ultrasound will subsequently be used for image guidance as the gold standard. Images will be compared and improved. The efficacy of the portable ultrasound will be monitored by the clinical user and any complications within 30 days will be determined by chart review.
Study NCT05379140 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Three Weekly Therapeutic Chinese Massage Sessions
Description: Participants in the therapeutic Chinese massage group received three weekly 25-minute therapeutic Chinese massage sessions. The intervention included acupressure to points along the distal lower extremity acupuncture points of the Gall Bladder Channel (GB 40 and then 34). Further Chinese Massage incorporates kneading, rolling, movement of the ankle, rotating, pulling, and scrubbing to the lower extremity.
Study NCT05379140 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Three Weekly Placebo Massage Sessions
Description: The placebo massage group received three weekly 25-minute placebo massage that included gentle rubbing to the foot and toes without point stimulation or other techniques of Chinese Massage. The control group had the opportunity to receive the treatment after the study was completed.
Study NCT05697432 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral Examination
Description: A complete examination of oral and dental hygiene any health problems will be registered
Study NCT05697432 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PUFA index
Description: An assessment of the presence of oral conditions resulting from untreated caries. P=Pulpal involvement, U=ulceration, F=fistula, A=abscess index
Study NCT05697432 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Plaque index
Description: An assessment of the amount of dental plaque visible on the vestibular and lingual surfaces of all teeth. The index varies between 0-4.
Study NCT05697432 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Streptococcus mutans screening
Description: A strip test for specific bacteria named streptococcus mutans, which plays an important role in caries formation, from patients' collected saliva
Study NCT05697432 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: Education on correct toothbrushing technique, oral hygiene, dietary education on foods detrimental for dental hygiene.
Study NCT05445687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative language intervention program
Description: Narrative language targets improving narrative macrostructure and microstructure.~The program will include 24 illustrated story sequences with a minimum of 5 sequences representing the main story elements: characters and setting; problems; internal response; actions; and consequence. Story icons will be designed to represent the main 5 elements to accompany storytelling and act as visual prompts.~Each story will reflect specific content with several target vocabulary words and complex morphosyntax. Each story will be followed by comprehension questions to facilitate understanding and answering question about stories.~The following procedure will be implemented with each story: Modeling, answering comprehension questions, retelling with icons and colored illustrations, retelling with icons only, and retelling without icons. This procedure is adapted from story champs intervention program
Study NCT05445687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional language intervention
Description: Language rehabilitation targets improving semantics, syntax, pragmatics and phonology.
Study NCT05812599 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Module
Description: The COVID Test Learning Module will present four multi-part character scenarios that someone might experience when considering testing for COVID-19. Participants will answer questions about the character's behavior. Accurate guidelines will be provided in response to each scenario to educate participants about what to do in nuanced COVID testing decision-making situations.
Study NCT05034887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan (T-DXd) monotherapy
Description: T-DXd will be administered at a dose of 6.4 mg/kg (decimal) by intravenous infusion every 21 days (3 weeks) for subsequent three cycles.
Study NCT05034887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-DXd, Durvalumab and Capecitabine Combination
Description: Administer each cycle over 21 days. T-DXd is administered by intravenous infusion at 5.4 mg/kg every 21 days (every 3 weeks). Capecitabine is given at 750 mg/m2 BID, taken orally for 14 days, followed by a drug holiday from the evening of Day 15 to the morning of Day 22 (Day 1 of the next cycle). Durvalumab is administered at 1500 mg by intravenous infusion over 60 minutes every 21 days (every 3 weeks). As neoadjuvant chemotherapy, administer T-DXd, Capecitabine, and Durvalumab in combination on a q3w schedule for 3 cycles. As adjuvant chemotherapy consists of T-DXd, Capecitabine, and Durvalumab in combination on a q3w schedule for 3 cycles, followed by Durvalumab monotherapy on a q4w schedule until 10 cycles are completed.
Study NCT05333081 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Consumption of rice for evaluation of the glycemic index
Description: The test of each food was carried out for a maximum time of 120 minutes, by carrying out repeated measurements of the glycaemia of all subjects at a distance of 0, 15, 30, 45, 60, 90 and 120 minutes from the administration of the sample in order to obtain a glycemic curve for each sample considered.
Study NCT05384002 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Patients who underwent MRI with confirmed pathology data (either biopsy or prostatectomy)
Study NCT06173310 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Point-of-care Portable Perfusion Phantom (P4)
Description: P4 is a perfusion phantom developed by Dr. Harrison Kim that can significantly reduce variation in quantitating perfusion of human abdominal tissues across MRI scanners.
Study NCT05854784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afamelanotide 16 MG
Description: Eligible patients will receive one dose of afamelanotide 16mg every 28 days (up to six doses), as a controlled-release formulation.
Study NCT05760677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pioglitazone group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
Description: the pioglitazone group： classic treatment: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
Study NCT05760677 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pioglitazone group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
Description: the pioglitazone group： classic treatment: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
Study NCT04896580 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nature based exercise
Description: Participants will engage in three months of moderate intensity PA, consisting of three 50-minute walking sessions per week (5-minute warm-up, 40 minute walk, 5 minute cool-down and stretch) with an exercise physiologist for 12 weeks.
Study NCT06468839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: digital addiction management model
Description: The experimental group will implement a digital addiction model. No intervention will be made to the control group.
Study NCT05760677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar
Description: the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar (32mg QD)
Study NCT05760677 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar
Description: the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar (32mg QD)
Study NCT05174702 — intervention group
Intervention type: RADIATION
Intervention: Irradiation collected at the end of the operation on the active dosimeter
Description: Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team
Study NCT06293859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Probiotic oat flakes
Description: 2 x 10\^9 cfu/g Lactococcus cremoris immobilized on oat flakes
Study NCT06293859 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional oat flakes
Description: Commercial oat flakes
Study NCT06702423 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI-based chatbot
Description: A tailored Japanese HPV vaccination chatbot.
Study NCT06702423 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Leaflet
Description: A publicly accessible HPV vaccination leaflet prepared by the Ministry of Health, Labour, and Welfare.
Study NCT05718999 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Not intervention
Description: Not having intervention is an observational study
Study NCT05084989 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
Description: 2 doses. Before reconstitution:Lyophilized powder for reconstitution in single-use vials; After reconstitution with BFA03 adjuvant: Milk-white solution with no visible foreign matter; Unite Does Strengths: 40ug/vial; Does Volume: 0.5ml/dose Routine of administration: Intramuscular (IM) injection
Study NCT05084989 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Part1: Placebo
Description: 2 doses. Before reconstitution: Lyophilized powder for reconstitution in single-use vials; After reconstitution with BFA03 adjuvant: Milk-white solution with no visible foreign matter; Unite Does Strengths: Not Applicable; Does Volume: 0.5ml/dose; Routine of administration: IM injection;
Study NCT06191211 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, AIMS
Description: Motivational interviewing (MI). MI is an approach to patient engagement which promotes a collaborative conversation style for strengthening a person's own motivation and commitment to change. With MI, the doctor facilitates patient exploration of potential reasons for behaviour change in the context of what is important to the patient, rather than the physician directly telling the patient what to do. MI has been found more effective than other approaches to patient engagement and health behaviour change and can be effectively taught to primary care providers.
Study NCT06191211 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility engagement
Description: A letter to the facility from the local health officials; a meeting with the facility manager and health staff to formally announce that we would like providers to encourage COVID-19 vaccinations; deploying a tracking sheet for vaccinations.
Study NCT05084989 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Part2: Recombinant two-component COVID-19 vaccine (CHO cell)
Description: 1 dose.Before reconstitution:Lyophilized powder for reconstitution in single-use vials; After reconstitution with BFA03 adjuvant: Milk-white solution with no visible foreign matter; Unite Does Strengths: 40ug/vial; Does Volume: 0.5ml/dose Routine of administrati
Study NCT05084989 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Part2: COVID-19 Vaccine, mRNA
Description: 1 dose. Intramuscular injection, 30 μg/0.3 mL.
Study NCT06191211 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Facility engagement
Description: A letter to the facility from the local health officials; a meeting with the facility manager and health staff to formally announce that we would like providers to encourage COVID-19 vaccinations; deploying a tracking sheet for vaccinations.
Study NCT05857956 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proper Wild energy shot
Description: 100% plant-based energy shot containing natural caffeine, L-Theanine, purified water, pineapple juice concentrate, natural flavors, kiwi juice concentrate, organic lemon juice concentrate, organic strawberry juice concentrate, monk fruit juice concentrate, pink himalayan sea salt.
Study NCT06213701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program
Description: HMP is a 4-week mobile health (mHealth) meditation training program.
Study NCT06213701 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation app
Description: Psychoeducation app
Study NCT04760132 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COMIRNATY - BioNTech Manufacturing GmbH
Description: Vaccination as part of the the Danish national government programme
Study NCT04760132 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH
Description: Vaccination as part of the the Danish national government programme
Study NCT04760132 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine AstraZeneca suspension for injection
Description: Vaccination as part of the the Danish national government programme
Study NCT05798962 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsies
Description: Biopsies from the pathological muscle and healthy, unaffected muscle
Study NCT06223425 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: virtual reality Situation-Based Flipped Learning
Description: Situation-Based Flipped Learning, and Gamification have gained attention as promising tools to engage nursing students and promote a deeper understanding of complex concepts. This study aims to investigate the effectiveness of combining these strategies in a virtual reality Situation-Based Flipped Learning environment with elements of Gamification on nursing students' learning attitudes, problem-solving abilities, and empathetic skills.
Study NCT05278793 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous fumarate
Description: Ferrous fumarate 200mg oral
Study NCT05278793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferrous fumarate
Description: Ferrous fumarate 200mg oral
Study NCT05603819 — intervention group
Intervention type: DEVICE
Intervention: EDIT-B
Description: To perform EDIT-B test, questionnaires and 2x0.5 mL whole blood are collected from each patient.
Study NCT05475171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorigerlimab
Description: Given by vein (IV)
Study NCT06103669 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ablative local therapy
Description: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy
Study NCT04999293 — intervention group
Intervention type: DRUG
Intervention: Ticagrelor
Description: Patients were survivors and treated with DAPT (aspirin \[100 mg once daily\], cilostazol, or indobufen)combined with a P2Y12 receptor antagonist \[clopidogrel (75 mg once daily) or ticagrelor (90 mg twice daily)\]) at the time of hospital discharge.All patients were followed for 1 year in the outpatient clinic after hospital discharge.
Study NCT05062772 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Intraoperative ultrasound imaging
Study NCT05504421 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sustainability education in nursing to be given with two different teaching methods
Description: Sustainability education in nursing to be given with two different teaching methods (cooperative learning versus traditional learning) and the effects of two different teaching methods on the sustainability knowledge, attitude and skill acquisition of nursing students will be compared.
Study NCT05275699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI
Description: Intravenous injection of one dosage of 18.5-22.2MBq (0.5-0.6 mCi)/Kg 68Ga-FAPI. Tracer doses of 68Ga-FAPI will be used to image lesions of keloid by PET/CT.
Study NCT05579548 — intervention group
Intervention type: DRUG
Intervention: Pegvaliase
Description: Pregnant women exposed to pegvaliase within 2 weeks prior to LMP.
Study NCT05504421 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sustainability education in nursing to be given with two different teaching methods
Description: Sustainability education in nursing to be given with two different teaching methods (cooperative learning versus traditional learning) and the effects of two different teaching methods on the sustainability knowledge, attitude and skill acquisition of nursing students will be compared.
Study NCT05200494 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Recruiting Maneuver
Description: Airway pressure will be increased to 30 cmH2O for 30 seconds at the end of the bronchoscopy
Study NCT06281301 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: education tool
Description: Participants will have 15 minutes to review the single sided card and then the survey will be administered. Participants will then be surveyed again within 1-2 weeks after initial completion to assess how well information was retained.
Study NCT06281301 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no additional information
Description: Survey will be administered without reviewing the single sided card
Study NCT04727281 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of life assessment using the Kidney Disease Quality of Life 36 (KDQOL-36) short form and Malnutrition-Inflammation Score
Description: Data about nutritional status using the Malnutrition-Inflammation Score, and Quality of life assessment using the Kidney Disease Quality of Life 36 (KDQOL-36) short form. Dialysis related data, The time needed for the patient to recover from a dialysis session (in minutes), Detailed history taking, Thorough physical examination, Laboratory Investigations:~• Hemoglobin , Serum sodium and potassium , Serum creatinine and blood urea , Serum phosphorus, serum calcium , Serum PTH level , Serum albumin ,CRP ,Total iron-binding capacity .
Study NCT06453876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound assisted Thrombolysis
Description: Please see Arms
Study NCT06052566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efinopegdutide
Description: Subcutaneous injection administered at a dose of 7 mg
Study NCT06453876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Embolectomy
Description: Please see arms
Study NCT06453876 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: Active comparator
Study NCT04972175 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 50-Hour Intervention - Rapid Insulin lispro
Description: Subcutaneous-delivery of insulin lispro using pump therapy.